Anti-Hu CD253 APC

Anti-Hu CD253 APC

• Background: Human CD253 / TRAIL (TNF-related apoptosis inducing ligand), also called Apo2, is a type II membrane protein from the TNF family. TRAIL is a cytotoxic protein which activates rapid apoptosis in tumor cells, but not in normal cells. TRAIL-induced apotosis, is achieved through binding to two dealth-signaling receptors, DR4 (CD261 / TRAIL-R1) and DR5 (CD262 / TRAIL-R2).
• Specifications: The antibody 2E5 reacts with an extracellular epitope within C-terminal half of TRAIL (APO-2L), a 21 kDa cytotoxic protein, activator of rapid apoptosis in tumor cells. TRAIL is mainly expressed in spleen, lung, prostate and also in many other tissues.
• CAS Number: 9007-83-4
• Certification: RUO
• Host: Mouse
• Species Reactivity: Human
• Negative Species: Mouse
• Immunogen: Recombinant soluble fragment (aa 95-281) of human TRAIL.
• Target Antigen: CD253
• Isotype: IgG1
• Clone: 2E5
• Applications: Flow cytometry: Recommended dilution: 1-5 μg/mL.
• Validated Applications: FC
• Concentration: 0.1 mg/mL
• Format: APC
• Buffer: Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
• References & Citations: *Hyer ML, Croxton R, Krajewska M, Krajewski S, Kress CL, Lu M, Suh N, Sporn MB, Cryns VL, Zapata JM, Reed JC: Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells. Cancer Res. 2005 Jun 165(11):4799-808., URL: https://www.ncbi.nlm.nih.gov/pubmed/15930300?dopt=,*Plasilova M, Zivny J, Jelinek J, Neuwirtova R, Cermak J, Necas E, Andera L, Stopka T: TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors. Leukemia. 2002 Jan16(1):67-73., URL: https://www.ncbi.nlm.nih.gov/pubmed/11840265?dopt=,
• Storage Conditions: Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.